Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Missed opportunities: despite improvement in use of cardioprotective medications among patients with lower-extremity peripheral artery disease, underuse remains

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{8b75d1dc2aed44a4a36b1f7c6bd311d5,
title = "Missed opportunities: despite improvement in use of cardioprotective medications among patients with lower-extremity peripheral artery disease, underuse remains",
abstract = "Patients with peripheral artery disease (PAD) are at high risk of cardiovascular events and benefit from aggressive secondary prevention; however, changes in the use of cardioprotective medications after incident diagnosis of PAD have not been well described.",
author = "Sumeet Subherwal and Patel, {Manesh R} and Lars Kober and Peterson, {Eric D} and Jones, {William S.} and Gislason, {Gunnar H} and Jeffrey Berger and Christian Torp-Pedersen and Fosbol, {Emil L}",
year = "2012",
doi = "10.1161/CIRCULATIONAHA.112.108787",
language = "English",
volume = "126",
pages = "1345--54",
journal = "Circulation (Baltimore)",
issn = "0009-7322",
publisher = "Lippincott Williams & Wilkins",
number = "11",

}

RIS

TY - JOUR

T1 - Missed opportunities

T2 - despite improvement in use of cardioprotective medications among patients with lower-extremity peripheral artery disease, underuse remains

AU - Subherwal, Sumeet

AU - Patel, Manesh R

AU - Kober, Lars

AU - Peterson, Eric D

AU - Jones, William S.

AU - Gislason, Gunnar H

AU - Berger, Jeffrey

AU - Torp-Pedersen, Christian

AU - Fosbol, Emil L

PY - 2012

Y1 - 2012

N2 - Patients with peripheral artery disease (PAD) are at high risk of cardiovascular events and benefit from aggressive secondary prevention; however, changes in the use of cardioprotective medications after incident diagnosis of PAD have not been well described.

AB - Patients with peripheral artery disease (PAD) are at high risk of cardiovascular events and benefit from aggressive secondary prevention; however, changes in the use of cardioprotective medications after incident diagnosis of PAD have not been well described.

U2 - 10.1161/CIRCULATIONAHA.112.108787

DO - 10.1161/CIRCULATIONAHA.112.108787

M3 - Journal article

VL - 126

SP - 1345

EP - 1354

JO - Circulation (Baltimore)

JF - Circulation (Baltimore)

SN - 0009-7322

IS - 11

ER -

ID: 36493032